Connection

Maria Lopes-Virella to Imipramine

Back to Details
This is a "connection" page, showing publications Maria Lopes-Virella has written about Imipramine.
Maria Lopes-Virella
Connection Strength
0.047
Imipramine
  1. Inhibition of acid sphingomyelinase by imipramine abolishes the synergy between metabolic syndrome and periodontitis on alveolar bone loss. J Periodontal Res. 2022 Jan; 57(1):173-185.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.